BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26694654)

  • 41. Use of the Internet in scanning the horizon for new and emerging health technologies: a survey of agencies involved in horizon scanning.
    Douw K; Vondeling H; Eskildsen D; Simpson S
    J Med Internet Res; 2003; 5(1):e6. PubMed ID: 12746211
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-criteria development and incorporation into decision tools for health technology adoption.
    Poulin P; Austen L; Scott CM; Waddell CD; Dixon E; Poulin M; Lafrenière R
    J Health Organ Manag; 2013; 27(2):246-65. PubMed ID: 23802401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A content analysis of Health Technology Assessment programs in Latin America.
    Arellano LE; Reza M; Blasco JA; Andradas E
    Int J Technol Assess Health Care; 2009 Oct; 25(4):570-6. PubMed ID: 19845988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GUIDING PRINCIPLES FOR GOOD PRACTICES IN HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT UNITS.
    Sampietro-Colom L; Lach K; Pasternack I; Wasserfallen JB; Cicchetti A; Marchetti M; Kidholm K; Arentz-Hansen H; Rosenmöller M; Wild C; Kahveci R; Ulst M
    Int J Technol Assess Health Care; 2015; 31(6):457-65. PubMed ID: 26899230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].
    Gibis B; Rheinberger P
    Z Arztl Fortbild Qualitatssich; 2002 Feb; 96(2):82-90. PubMed ID: 11921610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decisions to adopt new technologies at the hospital level: insights from Israeli medical centers.
    Greenberg D; Peterburg Y; Vekstein D; Pliskin JS
    Int J Technol Assess Health Care; 2005; 21(2):219-27. PubMed ID: 15921062
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Application of HTA research on policy decision-making.
    Youngkong S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S119-26. PubMed ID: 24964709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decision-Oriented Health Technology Assessment: One Step Forward in Supporting the Decision-Making Process in Hospitals.
    Ritrovato M; Faggiano FC; Tedesco G; Derrico P
    Value Health; 2015 Jun; 18(4):505-11. PubMed ID: 26091605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emerging health technologies: informing and supporting health policy early.
    Wild C; Langer T
    Health Policy; 2008 Aug; 87(2):160-71. PubMed ID: 18295925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UNTANGLING, UNBUNDLING, AND MOVING FORWARD: FRAMING HEALTH TECHNOLOGY REASSESSMENT IN THE CHANGING CONCEPTUAL LANDSCAPE.
    Soril LJJ; Niven DJ; Esmail R; Noseworthy TW; Clement FM
    Int J Technol Assess Health Care; 2018 Jan; 34(2):212-217. PubMed ID: 29616604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Resource allocation and health technology assessment in Australia: views from the local level.
    Gallego G; van Gool K; Kelleher D
    Int J Technol Assess Health Care; 2009 Apr; 25(2):134-40. PubMed ID: 19331706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Barriers and facilitators influencing ethical evaluation in health technology assessment.
    Assasi N; Schwartz L; Tarride JE; O'Reilly D; Goeree R
    Int J Technol Assess Health Care; 2015 Jan; 31(3):113-23. PubMed ID: 26179275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis.
    Wilson MG; Ellen ME; Lavis JN; Grimshaw JM; Moat KA; Shemer J; Sullivan T; Garner S; Goeree R; Grilli R; Peffer J; Samra K
    Syst Rev; 2014 Dec; 3():143. PubMed ID: 25495034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using health technology assessment to identify gaps in evidence and inform study design for comparative effectiveness research.
    Tunis SR; Turkelson C
    J Clin Oncol; 2012 Dec; 30(34):4256-61. PubMed ID: 23071248
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Social and ethical analysis in health technology assessment.
    Tantivess S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S81-6. PubMed ID: 24964703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spanish recommendations on economic evaluation of health technologies.
    López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J
    Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Joint report of the Council on Scientific Affairs and the Council on Medical Service. Technology assessment in medicine.
    Arch Intern Med; 1992 Jan; 152(1):46-50. PubMed ID: 1728928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [How can the impact of Health Technology Assessment (HTA) in the Austrian healthcare system be assessed? Design of a conceptual framework].
    Schumacher I; Zechmeister I
    Gesundheitswesen; 2012 Apr; 74(4):257-65. PubMed ID: 21267815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.